Financials in USD. Standardized financial statements.
A compact view of how IDEXX Laboratories, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $4.30B | $3.90B | $3.66B | $3.37B | $3.22B | $2.71B | $2.41B | $2.21B | $1.97B | $1.78B |
| Revenue Growth? | +10.4% | +6.5% | +8.7% | +4.7% | +18.8% | +12.5% | +8.8% | +12.4% | +10.9% | 0.0% |
| Cost of Revenue? | $1.64B | $1.52B | $1.47B | $1.36B | $1.33B | $1.14B | $1.04B | $971.70M | $871.68M | $799.99M |
| Gross Profit? | $2.66B | $2.38B | $2.19B | $2.00B | $1.89B | $1.57B | $1.37B | $1.24B | $1.10B | $975.44M |
| Gross Margin? | +61.8% | +61.0% | +59.8% | +59.5% | +58.8% | +58.0% | +56.7% | +56.1% | +55.7% | +54.9% |
| Operating Expenses? | $1.30B | $1.25B | $1.09B | $1.11B | $957.40M | $876.52M | $812.70M | $750.21M | $684.35M | $625.20M |
| Operating Income? | $1.36B | $1.13B | $1.10B | $898.76M | $932.03M | $694.52M | $552.85M | $491.33M | $413.03M | $350.24M |
| EBITDA? | $1.47B | $1.28B | $1.22B | $1.01B | $1.04B | $793.81M | $643.68M | $575.66M | $501.42M | $431.69M |
| Income Before Tax | $1.32B | $1.11B | $1.06B | $859.97M | $902.65M | $661.99M | $522.22M | $457.74M | $381.06M | $321.85M |
| Income Tax Expense | $264.73M | $221.96M | $216.13M | $180.88M | $157.81M | $79.85M | $94.43M | $80.69M | $117.79M | $99.79M |
| Net Income? | $1.06B | $887.87M | $845.04M | $679.09M | $744.85M | $581.78M | $427.72M | $377.03M | $263.14M | $222.04M |
| EPS? | $13.17 | $10.77 | $10.17 | $8.12 | $8.74 | $6.82 | $4.97 | $4.34 | $3.00 | $2.47 |
| Diluted EPS? | $13.08 | $10.67 | $10.06 | $8.03 | $8.60 | $6.71 | $4.89 | $4.26 | $2.94 | $2.44 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality